Cite
HARVARD Citation
Ma, T. et al. (2022). EZH2-mediated suppression of CLDN1 leads to barrier dysfunction in PPI-refractory gastroesophageal reflux disease. Digestive and liver disease. 54 (6), pp. 776-783. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, T. et al. (2022). EZH2-mediated suppression of CLDN1 leads to barrier dysfunction in PPI-refractory gastroesophageal reflux disease. Digestive and liver disease. 54 (6), pp. 776-783. [Online].